18
Dec

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

An excellent study about the use of AT III in septic patients. Carefully conducted study: the description in the method section is outstanding. It is noteworthy that this is the presentation of a study with negative results.

– W. Dietrich.